Oakland Tribune Examines OraQuick Rapid HIV Test That 'Could Alter' HIV Diagnosis, Treatment
August 6, 2003
The Oakland Tribune on Monday examined the use of OraSure's OraQuick rapid HIV test, which can deliver a result in about 20 minutes, saying that the test "could alter diagnosis and treatment for thousands." An estimated 25% of the almost one million HIV-positive people in the United States are unaware of their status, according to the CDC, partly because nearly 50% of people who undergo HIV testing never return for their results. However, with the OraQuick test, "there's little time to ponder the outcome," which can present a challenge for HIV counselors who must deliver the results to clients, according to the Tribune. Although a traditional laboratory-based antibody test is required to confirm any positive OraQuick result, the test did not have any false-positive results in clinical trials (Vesely, Oakland Tribune, 8/4). The complete article is available online.
This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily HIV/AIDS Report. Visit the Kaiser Family Foundation's website to find out more about their activities, publications and services.
The content on this page is free of advertiser influence and was produced by our editorial team. See our advertising policy.